The proportion of clinical and definitive TBM was significantly higher (p < 0.001) in the patients with elevated CSF-ADA (26/144, 18.1%) than in the patients without CSF-ADA (14/2,456, 0.6%). This evidence concerns the gene ADA and meningeal tuberculosis.